A new, easy-to-read booklet ? Stay Safe in Cold Weather! ? offers older adults tips on avoiding a dangerous condition called hypothermia. This free 12-page publication is now available from the National Institute on Aging (NIA), a part of the National Institutes of Health (NIH).
A multicenter study on treating common ear infections in children with ear tubes adds to a growing body of evidence that favors antibiotic ear drops over antibiotics swallowed in pill or liquid form in such cases, a UT Southwestern Medical Center researcher reports.
A new study, published in the journal Neurology, revealed that brain imaging shows unusual pattern of brain activity in cases of hysteria or conversion disorders.
At the American Society of Hematology meeting in Orlando AkaRx, Inc. presented the positive results from two Phase I studies of AKR-501, an investigational compound for the treatment of thrombocytopenia.
According to a new article in the American Journal of Gastroenterology, gastroesophageal reflux disease (GRD), more commonly known as, acid reflux, is linked to obesity. Since (GRD) is strongly associated with more serious conditions, such as esophageal ulcers and cancer, weight reduction therapy may be useful in treatment and prevention of these conditions.
Although some Americans gain five to seven pounds with a diet of big meals and sweets between Thanksgiving and New Year’s Day, most people only gain a pound or two during the holidays, according to a UT Southwestern Medical Center registered dietitian.
A natural substance made from soy appears to have amazing restorative powers when given to animals with a multiple sclerosis (MS)-like disease.
A new study suggests that a program focusing on increasing step length and speed is more effective at improving mobility and balance than tai chi. While tai chi — a Chinese martial art form consisting of slow, rotational movements and weight-shifting — offers many benefits, the researchers say, they’re not as great as those produced by a balance-training program.
Dr. Alan List, from the H. Lee Moffitt Cancer Center & Research Institute, presented the final results from a pivotal Phase II trial evaluating Revlimid in patients with an incurable blood cancer known as myelodysplastic syndromes (MDS) at this year’s American Society of Hematology (ASH) meeting.
VIB and AlgoNomics have joined forces to develop a technology that verifies whether certain proteins induce an immune response in humans. The collaboration between VIB and AlgoNomics has yielded a biological test that supplements the current computer simulations. The additional data enable a more precise determination of the immune response.